Early Cancer Detection

Unlocking Proactive Health with Episeek: Advanced Cancer Screening at Avovita Wellness

At Avovita Wellness in Calgary, we're dedicated to empowering you with the most advanced tools for proactive health management. That's why we offer Episeek, a revolutionary blood test that goes beyond traditional screening methods. Episeek analyzes your unique epigenetic signature to detect potential cancer signals at the earliest stages, giving you a critical advantage in your health journey.

What Cancers Does Episeek Screen For?

Episeek is designed to screen for a broad spectrum of cancers, including some of the most prevalent and challenging: lung, breast, prostate, colorectal, head and neck, bladder, esophageal, and more. This comprehensive approach provides a more complete picture of your cancer risk, empowering you to make informed decisions about your health.

Understanding Sensitivity and Specificity: Precision You Can Trust

We understand that accuracy is paramount. Episeek boasts an impressive 99% specificity, meaning it's highly reliable in identifying individuals who are cancer-free. This minimizes the risk of unnecessary anxiety and follow-up procedures. Sensitivity varies depending on the stage of the cancer. For aggressive stage 1 and 2 cancers the sensativity is around 57%. For stage 3 cancers, the sensativity is around 73%. While no test is perfect, Episeek's advanced technology provides a powerful tool for early detection.

At AvoVita Wellness in Calgary, we are committed to bringing you the most advanced and effective tools for proactive health management. Among our premier offerings is Lucence Insight, a cutting-edge liquid biopsy test that represents a significant leap forward in early cancer detection. This innovative technology analyzes circulating tumor DNA (ctDNA), which are tiny fragments of DNA shed by cancer cells into the bloodstream. By examining a simple blood sample, Lucence Insight can identify these minute traces of cancerous DNA, providing a non-invasive window into the body's cellular health.

Unlike traditional diagnostic methods that often rely on imaging or invasive biopsies to detect tumors once they have grown to a significant size, Lucence Insight has the potential to identify cancer signals much earlier. This is because ctDNA can be present even when the tumor is small and has not yet caused noticeable symptoms. The test goes beyond simply detecting the presence of ctDNA; it also performs comprehensive genomic profiling, identifying specific genetic alterations associated with various cancer types. This detailed molecular information can be invaluable for understanding the characteristics of any detected cancer and potentially guiding personalized treatment strategies in the future. Lucence Insight offers a powerful and convenient way for individuals in Calgary to gain a deeper understanding of their cancer risk and take proactive steps towards safeguarding their long-term health.

Selecting Lucence Insight at AvoVita Wellness in Calgary for your early cancer screening offers a multitude of compelling advantages. Firstly, its non-invasive nature stands out as a significant benefit. Unlike traditional biopsies, which can be uncomfortable and carry certain risks, Lucence Insight requires only a simple blood draw, making it a more convenient and less stressful experience. This ease of access encourages regular screening and proactive health management for individuals in Calgary.

Secondly, Lucence Insight's capability to screen for multiple cancer types simultaneously from a single blood sample provides a comprehensive overview of potential risks. This broad approach increases the likelihood of early detection across a spectrum of malignancies, offering a more holistic assessment of your health compared to single-cancer screening methods.

The core strength of Lucence Insight lies in its ability to detect circulating tumor DNA (ctDNA). This allows for the identification of cancer signals at a much earlier stage, often before tumors are large enough to be detected by conventional imaging techniques or cause noticeable symptoms. This early insight is critical because treatment outcomes are generally far more favorable when cancer is detected and addressed in its initial stages. For Calgarians seeking to maximize their chances of successful cancer management, this early detection capability is paramount.

Furthermore, the advanced genomic profiling provided by Lucence Insight offers valuable information beyond just the presence of cancer. By identifying specific genetic alterations within the ctDNA, the test can potentially provide insights into the type and characteristics of the cancer. This detailed molecular information can be crucial for guiding personalized treatment decisions should cancer be detected, ensuring a more targeted and effective approach to care in collaboration with your healthcare provider in Calgary. By choosing Lucence Insight at AvoVita Wellness, you are investing in a cutting-edge screening tool that prioritizes convenience, comprehensiveness, early detection, and the potential for personalized insights, empowering you to take proactive control of your health in Calgary.

While both EpiSeek and Lucence Insight are advanced blood tests for early cancer detection offered at AvoVita Wellness in Calgary, they utilize different biological markers and approaches:

EpiSeek focuses on epigenetic analysis, specifically looking at DNA methylation patterns. These are chemical modifications to DNA that can influence gene activity without altering the underlying genetic code. Cancer cells often exhibit distinct methylation patterns compared to healthy cells. EpiSeek analyzes these abnormal methylation patterns in circulating tumor DNA (ctDNA) to identify potential early cancer signals across a range of cancer types. Think of it as looking for specific "flags" attached to the DNA that indicate cancerous changes.

Lucence Insight, on the other hand, primarily focuses on genomic analysis of circulating tumor DNA (ctDNA). It directly sequences the DNA fragments in the blood to identify genetic mutations, copy number variations, and other DNA alterations that are characteristic of cancer cells. Lucence Insight aims to detect the presence of these specific cancer-associated genetic changes to provide early detection and potential insights into the type of cancer and its characteristics. Imagine this as searching for specific "misspellings" or alterations within the DNA sequence itself that are indicative of cancer.